Centessa Pharmaceuticals plc ADR (CNTA) Stock: Navigating Market Highs and Lows in 52 Weeks

Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Centessa Pharmaceuticals plc ADR’s current trading price is 4.04% away from its 52-week high, while its distance from the 52-week low is 208.67%. The stock’s price range during this period has varied between $3.00 and $8.90. The company, active in the Healthcare sector, saw a trading volume of around 249.12 for the day, considerably higher average daily volume of 12.14 observed over the last three months.

Centessa Pharmaceuticals plc ADR’s stock has had a calm market performance. The 1-year high for the company’s stock was $8.90 on 02/09/24, and the lowest price during the same period was recorded at $3.00 on 02/21/23.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

How Financial Performance Impacts Market Capitalization

Centessa Pharmaceuticals plc ADR (CNTA) has experienced a quarterly rise of 36.18% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 903.50M.

The Role of Moving Averages and Trading Volume in Technical Analysis

Based on Barchart.com data, the company’s moving average over the 100-day period was 6.97, with a change in price of +2.77. Similarly, Centessa Pharmaceuticals plc ADR recorded 238,072 in trading volume during the last 100 days, posting a change of +42.68%.

How CNTA’s Debt-to-Equity Ratio Affects Financial Health

A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for CNTA stands at 0.32. Similarly, the long-term debt-to-equity ratio is also 0.32.

CNTA Stock Stochastic Average

As of today, the raw stochastic average of Centessa Pharmaceuticals plc ADR over the past 50 days is 96.23%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 94.33%. Additionally, the Stochastic %K and %D values for the company were 57.07% and 54.04%, respectively, over the past 20 days.

CNTA Stock Price Performance Analysis

The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Year to date metric has recorded a gain of 16.33%.However, over the last six months, we can see a weaker performance of 41.59%. Over the last 30 days, the price of CNTA has fallen by 32.86%. And in the last five days, it has surged by 17.66%.

Leave a Reply

Your email address will not be published. Required fields are marked *

On Key

Related Posts